AstraZeneca
AZN
#50
Rank
S$364.67 B
Marketcap
S$235.23
Share price
-1.40%
Change (1 day)
29.92%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): S$7.78

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$7.55. In 2024 the company made an earnings per share (EPS) of S$5.78 an increase over its 2023 EPS that were of S$4.89.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$7.7834.54%
2024S$5.7818.23%
2023S$4.8981.13%
2022S$2.70631.03%
2021S$0.37-88.11%
2020S$3.11136.89%
2019S$1.31-39.41%
2018S$2.16-28.27%
2017S$3.02-14.37%
2016S$3.5224.11%
2015S$2.84127.55%
2014S$1.25-51.96%
2013S$2.60-58.95%
2012S$6.33-32.2%
2011S$9.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.18 87.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.17 21.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.73-77.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.78-36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.32 288.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.63-65.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$11.24 48.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.31 23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.41-41.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.80-36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK